Insider Trading Activity BioAmber Inc. (NYSE:BIOA) – CFO Bought 15,000 shares of Stock

0

Insider Trading Activity For BioAmber Inc. (NYSE:BIOA)

Mario Settino , CFO of BioAmber Inc. (NYSE:BIOA) reportedly Bought 15,000 shares of the company’s stock at an average price of 0.53 for a total transaction amount of $7,950.00 SEC Form

Insider Trading History For BioAmber Inc. (NYSE:BIOA)

  • On 8/15/2013 Kurt W Briner, Director, bought 13,000 with an average share price of $5.49 per share and the total transaction amounting to $71,370.00.View SEC Filing
  • On 8/29/2013 Jean-Francois Huc, CEO, bought 5,000 with an average share price of $4.25 per share and the total transaction amounting to $21,250.00.View SEC Filing
  • On 9/3/2013 Michael A Hartmann, EVP, bought 2,000 with an average share price of $4.63 per share and the total transaction amounting to $9,260.00.View SEC Filing
  • On 11/14/2013 Kurt W Briner, Director, bought 7,200 with an average share price of $6.95 per share and the total transaction amounting to $50,040.00.View SEC Filing
  • On 5/12/2014 Michael A Hartmann, EVP, bought 2,500 with an average share price of $10.05 per share and the total transaction amounting to $25,125.00.View SEC Filing
  • On 5/12/2014 Andrew P Ashworth, CFO, bought 3,000 with an average share price of $10.00 per share and the total transaction amounting to $30,000.00.View SEC Filing
  • On 7/16/2014 Michael A Hartmann, EVP, bought 3,000 with an average share price of $12.00 per share and the total transaction amounting to $36,000.00.View SEC Filing
  • Analyst Ratings For BioAmber Inc. (NYSE:BIOA)
    These are 1 Hold Rating .
    The current consensus rating for BioAmber Inc. (NYSE:BIOA) is Hold (Score: 2.00) with a consensus target price of $3.00 , a potential (527.35% upside)

    Analyst Ratings History For BioAmber Inc. (NYSE:BIOA)

    • On 1/5/2016 Rodman & Renshaw Initiated Coverage of rating Buy with a price target of $18.00
    • On 1/5/2016 HC Wainwright Reiterated Rating Buy with a price target of $18.00
    • On 3/28/2016 Credit Suisse Group Boost Price Target of rating Outperform with a price target of $15.00 to $17.00
    • On 8/7/2016 Canaccord Genuity Reiterated Rating Buy with a price target of $5.50
    • On 3/13/2017 AltaCorp Capital Downgraded rating Outperform to Speculative
    • On 7/17/2017 Cowen and Company Set Price Target of rating Hold with a price target of $3.00

    Recent Trading Activity for BioAmber Inc. (NYSE:BIOA)
    Shares of BioAmber Inc. closed the previous trading session at 0.478 down -0.055 -10.37% with 874,930 shares trading hands.

    An ad to help with our costs